The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Status of reports of adverse events related to botanical herbal medicines with toxic precautions officially managed by Korean government: A descriptive analysis from WHO VigiAccess

WHO VigiAccess에 수록된 식물성 독성주의한약재 관련 이상사례 보고 현황

  • Mikyung Kim (Department of Internal Medicine, Dongguk University Ilsan Oriental Medicine Hospital)
  • 김미경 (동국대학교 일산한방병원 한방내과)
  • Received : 2024.01.23
  • Accepted : 2024.02.16
  • Published : 2024.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This study was aimed to review the global status of adverse event (AE) reports and the characteristics of the reported AEs of plants managed as herbal medicines (HMs) with toxic precautions in Korea. Methods: This is a cross-sectional quantitative study that analyzed information available through VigiAccess, a website that provides summarized statistical information from the WHO's global AE database to the public. VigiAccess was searched in 8 Jan, 2024. Information on the total number of reports, number of reports by year and continent, and the age and gender of patients were obtained, and the types of frequently reported AEs were also reviewed. Results: Data on the status of report submissions were obtained for a total of 9 HMs including Aconitum ciliare, Aconitum carmichaeli, Arisaema japonicum, Pinellia ternata, Euphorbiae Lathyridis, Croton tiglium, Strychni Ignatii, Strychnons nux-vomica, and Linum usitatissimum. The number of reports per HM was from 1 to 137. The most commonly reported type of AEs were gastrointestinal disorders in most of the HMs, followed by neurological disorders. Serious adverse events were reported only in Strychni Ignatii, Strychnons nux-vomica, and Linum usitatissimum, including one case of death. Conclusions: This study shows the status of reported AEs of botanicals considered as HMs with toxic precautions in Korea based on real world data. However, when interpreting the findings of this study, readers should consider the significant limitations of this study mainly because of the characteristics of the data source.

Keywords

References

  1. Ministry of Food and Drug Safety. [administrative regulations] Herbal medicine safety and quality control regulations. 2016 [cited 2024 7 Feb]; Available from: https://www.law.go.kr/admRulLsInfoP.do?admRulSeq=2100000043697
  2. Faculty of Internal Medicine of Liver System of Korean Medicine. (2016). Textbook of Internal Medicine of Liver System in Korean Medicine. Seoul: Book Publisher Nadoh. 871-889.
  3. Federation of Herbal Formula Professors of Colleges of Korean Medicine. (2019). Textbook of Herbal Formula. Seoul: Yeonglimsa.
  4. Kwon, D. (2008). [Research project report] Studies on control and management of medicinal herbs for poisonous concern. Korea Food and Drug Administration.
  5. World Health Organization. (2023). Programmed for International Drug Monitoring. [cited 2024 Jan 21]. Available from: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/networks/pidm
  6. World Health Organization. (2024). [cited 2024 Jan 21]. Available from: https://www.vigiaccess.org/
  7. Yamoah P, Mensah KB, Attakorah J, Padayachee N, Oosthuizen F, Bangalee V, Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess. Human Vaccines & Immunotherapeutics, 2022;18(6):2109365.
  8. Pandey, D., Mehta, G., Sachdeva, M., Tripathi, R. (2022). Adverse Event Following Immunization (AEFI) in Children: An Analysis of Reporting in VigiAccess. Drug Research (Stuttgart), 72(8), 435-440. https://doi: 10.1055/a-1852-5335. Epub 2022 Jun 20
  9. Li, M., You, R., Su, Y., Zhou, H., Gong, S. (2023). Characteristic analysis of adverse reactions of five anti-TNFα agents: a descriptive analysis from WHO-VigiAccess. Frontiers in Pharmacology, 14, 1169327. https://doi: 10.3389/fphar.2023.1169327.eCollection 2023
  10. He, M., Zhou, J., Yang, T., Li, X., Wang, R. (2023). Real-world study of antifibrotic drugs-related adverse events based on the United States Food and Drug Administration Adverse Event Reporting System and VigiAccess databases. Authorea, https://doi/full/10.22541/au.168672965.58074889/v1
  11. Sun, W., Zhang, W., Cai, Y., Huang, R., Gong, S. (2023). Characteristic Analysis of Adverse Reactions of Five PD-1/PD-L1 Anti-cancer Monoclonal Antibodies Based on WHO-VigiAccess. HERALD OF MEDICINE, 42(6), 851-858. https://doi:10.3870/j.issn.1004-0781.2023.06.012
  12. Ko, Y., Yun, S., Kim, M., Song, Y., Shin, B. (2005). Literatural Study on Toxicity of Herbs used in . Journal of Physiology & Pathology in Korean Medicine, 19(05), 1120-1128.
  13. Kim, J., Lee, G., Choi, G., Kim, Y., Lee, S., Kim H. (2021). Review on the mechanism for the reduction of raphide-induced toxicity via processing of Pinelliae Tuber and Arisaematis Rhizoma. The Korea Journal of Herbology, 36(5), 15-27. http://dx.doi.org/10.6116/kjh.2021.36.5.15.
  14. Kim, J., Lee, J., Song, G., Park, S., Kim, Y., Ha, H. (2022). [Research project report] Studies on liver toxicities induced by traditional herbal administrations. Korea Food and Drug Administration.
  15. Jang, I., Yang, C., Lee, S., Han, C. (2007). A Review of Herbal Medicinal Products Associated with Toxic Events in Korea. The Journal of Korean Oriental Internal Medicine, 1, 67-74.
  16. Zhang, A., Li, Z., Qi, G., Xu, Z., Liu, X., Ma, J., et al. (2022). Study of Pinelliae Rhizoma hepatotoxicity based on complex network algorithm improvement. bioRxiv, 2022.11. 29, 518337. https://doi.org/10.1101/2022.11.29.518337.
  17. Song, X., Yang, D., Wang, Y., Liu, W., Wang, Y., Zhu, J. (2019). Pharmacokinetic, acute toxicity, and pharmacodynamic studies of Semen Strychni total alkaloid microcapsules. Tropical Journal of Pharmaceutical Research, 18(9), 1985-1992. https://doi:10.4314/tjpr.v18i9.29.
  18. Korea Institute of Oriental Medicine. OASIS Encyclopedia of Medicinal Products. [cited 2024 21 Jan]; Available from: https://oasis.kiom.re.kr/oasis/herb/monoSearch.jsp?srch_menu_nix=87Z2RM16.
  19. Carraro, J. C. C., Dantas, M. I. de S., Espeschit, A. C. R., Martino, H. S. D. M., Ribeiro, S. M. R. (2012). Flaxseed and human health: reviewing benefits and adverse effects. Food Reviews International, 28(2), 203-230. https://doi.org/10.1080/87559129.2011.595025.
  20. Kim, M., Han, C. (2017). Adverse drug reactions in Korean herbal medicine: A prospective cohort study. European Journal of Integrative Medicine, 9, 103-9. https://doi.org/10.1016/j.eujim.2016.11.016.
  21. Park, Y., Park, H. M., Lee, S. (2011). Inducible Mechanisms for Hepatotoxicity caused by Traditional Korean Medicines in a View of Toxicology. Journal of Korean Medicine, 32(4), 48-67.
  22. Edwards, I.R., Aronson, J.K. (2000). Adverse drug reactions: definitions, diagnosis, and management. The Lancet, 356(9237), 1255-1259. https://doi:10.1016/S0140-6736(00)02799-9.
  23. World Health Organization. How UMC detects signals. (2022) [cited 2024 21 Jan]; Available from: https://who-umc.org/signal-work/signal-detection/.
  24. van Puijenbroek, E.P., Bate, A., Leufkens, H.G., Lindquist, M., Orre, R., Egberts, A.C. (2002). A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology and drug safety, 11(1), 3-10. https://doi:10.1002/pds.668.
  25. Kim, M., Woo, Y., Han, C-h. (2021). Current status of the spontaneous reporting and classification/coding system for herbal and traditional medicine in pharmacovigilance. Integrative Medicine Research, 10(1), 100467. https://10.1016/j.imr.2020.100467.
  26. Kim, M. (2020). Effect of A Pharmacovigilance Practice Training Course for Future Doctors of Korean Medicine on Knowledge, Attitudes and Self Efficacy. Journal of Korean Medicine, 41(1):21-44. https://doi.org/10.13048/jkm.20003.
  27. Jordan, S.A., Cunningham, D.G., Marles, R.J. (2010). Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicology and Applied Pharmacology, 243(2), 198-216. https://doi.org/10.1016/j.taap.2009.12.005.
  28. van Hunsel, F., van de Koppel, S., Skalli, S., Kuemmerle, A., Teng, L., Wang, J.B., et al. (2019). Analysis of Hepatobiliary Disorder Reports Associated With the Use of Herbal Medicines in the Global Suspected ADR Database Vigibase. Frontiers in Pharmacology, 10, 1326. https://doi:10.3389/fphar.2019.01326.
  29. Hsieh, S.C., Lai, J.N., Chen, P.C., Chen, H.J., Wang, J.D. (2006). Development of active safety surveillance system for traditional Chinese medicine: an empirical study in treating climacteric women. Pharmacoepidemiology and Drug Safety, 15(12), 889-899. https://doi:10.1002/pds.1340.